Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in
5 (513) · € 22.99 · En Stock
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study - The Lancet
Boosting of serum neutralizing activity against the Omicron variant among recovered COVID-19 patients by BNT162b2 and CoronaVac vaccines - eBioMedicine
Emergence of the SARS-CoV-2 Omicron Variant: Current Treatments and Vaccines for COVID-19
Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis
Effectiveness of CoronaVac vaccination against COVID-19 development in healthcare workers: real-life data
Immunological responses and adverse reactions of the heterologous second booster dose of BNT162b2 after two-dose CoronaVac for COVID-19 vaccination in healthcare workers of Faculty of Medicine, Naresuan University - ScienceDirect
Omicron BA.1-specific T-cell responses in adults vaccinated with CoronaVac or BNT162b2 in Hong Kong: an observational cohort study - The Lancet Microbe
Frontiers Effectiveness of SARS-CoV-2 vaccines against Omicron infection and severe events: a systematic review and meta-analysis of test-negative design studies
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study - ScienceDirect
Antibody Responses and Reactogenicity of a Heterologous, Full-Dose Messenger RNA-1273 Booster in Heavily SARS-CoV-2–Exposed CoronaVac- Vaccinated Health-Care Workers in Indonesia: A Real-World Observational Study in: The American Journal of Tropical
Humoral and cellular responses to vaccination with homologous CoronaVac or ChAdOx1 and heterologous third dose with BNT162b2 - Journal of Infection
Antibody Responses and Reactogenicity of a Heterologous, Full-Dose Messenger RNA-1273 Booster in Heavily SARS-CoV-2–Exposed CoronaVac- Vaccinated Health-Care Workers in Indonesia: A Real-World Observational Study in: The American Journal of Tropical
Vaccine effectiveness of two and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong
/product/69/0342/1.jpg?1485)
